Stock Selection: Muse Spark 1.1's picks for 2026-09-10
Muse Spark 1.1 picked ORCL, AVAV, SNDK, CEG, CBRS for a 1-day horizon. Portfolio return vs SPY: -1.43%. Picks that beat SPY: 20%.
| Experiment | Stock Selection |
|---|---|
| Model | Muse Spark 1.1 |
| Prompt version | stock-selection-v6 |
| Asked | |
| Horizon | 1-day |
| Measured from | 2026-09-09 |
| Measured to | 2026-09-10 |
| Benchmark | SPY |
| Status | Settled |
| Portfolio return vs SPY | -1.43% |
| Picks that beat SPY | 20% |
| Benchmark return | -0.60% |
The picks
| Rank | Symbol | Return | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|
| 1 | ORCL | -5.38% | 78% | -4.78% | No |
| 2 | AVAV | +4.45% | 72% | +5.05% | Yes |
| 3 | SNDK | -4.06% | 71% | -3.46% | No |
| 4 | CEG | -2.70% | 69% | -2.10% | No |
| 5 | CBRS | -2.48% | 67% | -1.88% | No |
The model's market view
Source close Sep 9: SPY $765.88 baseline, AVAV $140.80 -5.36% after $148.78, COO $63.48 -6.22%, ORCL $161.63 -0.55% with 5-day +8.39%, ADBE $254.86 -0.93% 5-day -12.95%, CAL $11.74 -3.61% after Q2 miss but +5.2% intraday spike. Target Sep 10 has ORCL and ADBE earnings after close officially scheduled Sep 2 and Aug 31. Macro: $638B Oracle RPO backlog, 58-64% OCI growth guide, Mizuho $320 Outperform, Broadcom $34.8B AI guide supports AI infra. Expect risk-on tech led by ORCL anticipation, plus rebound in oversold defense AVAV after Q1 print Sep 9 after close, and continued momentum in memory SNDK, nuclear CEG, and custom chip CBRS to outperform SPY.
Why each pick
ORCL
Oracle Q1 FY27 after close Sep 10 officially scheduled Sep 2 PRNewswire, consensus $1.74 EPS $19.13B revenue, prior beat $2.11 vs $1.96. Preview $638B backlog, 58-64% cloud growth. Closed $161.63 Sep 9 -0.55% but +8.39% 5-day off 52-week low $114.54. Pre-earnings momentum into close likely outperforms SPY as traders position long before backlog update. Risks: high expectations, 55% off ATH $345, guide must meet 27-29% growth.
AVAV
AeroVironment Q1 FY27 reported after close Sep 9, consensus $0.30 $459.9M, stock closed $140.80 -5.36% Sep 9 YTD -41.79% from ATH $409.83 Oct 2025. Defense drone demand and DoD contracts substantive catalyst. Oversold into print creates reversal potential Sep 10 regular session to outperform SPY if results beat muted growth. Market cap $7.35B. Risks: -38% 6-month, continued defense budget uncertainty.
SNDK
SanDisk closed $1737.99 Sep 8 -0.12% but 5-day +17.04% 1-month +43.37% and 1-year +2365% from $27.89 Apr 2025 low, beta 3.86. NAND pricing upcycle driven by AI storage, sympathy with ORCL OCI growth. High momentum name with $1,807 intraday high Sep 8. Likely outperforms SPY on AI infrastructure bid Sep 10. Risks: parabolic move, insider sale at $1767, volatility.
CEG
Constellation Energy closed $299.05 Sep 8 +0.11% 5-day +8.06% 1-month +10.8% market cap $105.92B, utilities only green Sep 4. Nuclear power for AI data centers, IRA support, grid reliability narrative. Defensive with AI kicker outperforms SPY when yields volatile into ORCL earnings. Risks: rate sensitivity, YTD -15% from ATH $401.70, valuation rich.
CBRS
Cerebras Systems closed $199.77 Sep 8 -4.89% from $210.05 previous, 5-day +11.55% 1-month -11.89% off high $386.34. Announced Finland AI data center, custom AI accelerator benefiting from ORCL and Broadcom AI capex $21.7B +236% YoY. High beta 5.21 market cap $47B. Oversold bounce Sep 10 likely outperforms SPY as ORCL anticipation lifts AI infra. Risks: -48% off high, competitive vs NVDA, volatile.
Other models on the same run
| Model | Picks | Portfolio return vs SPY | Picks that beat SPY |
|---|---|---|---|
| GPT-5.6 Sol | AVAV, XLE, AAPL, META, ORCL | +0.73% | 60% |
| Gemini 1.5 Pro | META, CVX, AVAV, HRL, NXT | +0.74% | 40% |
| Grok 4.5 | XOM, XLE, AVAV, META, NET | +1.02% | 60% |
| Gemini 3 Pro | AVAV, META, AAPL, ONON, ORCL | +0.85% | 60% |
| Kimi | VLO, XLE, META, XOM, CULP | +2.09% | 60% |
| Claude Opus 5 | CC, AVAV, XLE, DD, MRVL | +0.63% | 80% |
Written up on ForecastNest Insights: Stock Selection: Muse Spark 1.1's picks for 2026-09-10.
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.